RECOVERY- Delivery Order Notification-2009 VFA 200-2009-30521 GSK

RECOVERY - Delivery Order Notification THIS NOTICE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY UNDER THE AMERICAN RECOVERY AND REINVESTMENT ACT PROGRAM. The Centers for Disease Control and Prevention (CDC) intends to issue a delivery order against an Indefinite Delivery Indefinite Quantity Contract (Contract Number 200-2009-30521) GlaxoSmithKline (GSK) Holdings (Americas) Inc. for the following vaccines: Twinrix® / NDC: 58160-0815-11/ 972 doses Havrix® /NDC: 58160-0826-11 / 7,091 doses Engerix® / NDC: 58160-0821-11 / 5,385 doses Boostrix® /NDC 58160-0842-11/ 33,460 doses The delivery order will be funded through the American Recovery and Reinvestment Act of 2009. This opportunity is available only to GlaxoSmithKline (GSK) Holdings (Americas) Inc. under Contract Number 200-2009-30521 which was previously competed and awarded in fiscal year 2009 This is not a request for competitive proposals, nor is a solicitation available. This notice is provided for informational purposes under the American Recovery and Reinvestment Act (ARRA) Program. Any questions regarding this notice must be submitted in writing to Russell Oxford at [email protected]